Changes in cell-mediated immunity in patients undergoing radiotherapy.

Area of Science:

• Immunology
• Oncology
• Radiotherapy

Background:

• Radiotherapy is a common cancer treatment.
• Its impact on cell-mediated immunity requires further investigation.
• Understanding immune response to radiotherapy is crucial for patient outcomes.

Purpose of the Study:

• To evaluate the effects of radiotherapy on cell-mediated immune status.
• To assess immune response in cancer patients before and after radiation therapy.
• To explore the relationship between tumor characteristics and immune function.

Main Methods:

• In vitro immunological assays: phytohemagglutinin (PHA) stimulation, E-rosette formation, and spontaneous blastogenesis.
• Patient cohort: 147 individuals with verified malignancies (lung, breast, gynecological, head/neck, bladder).
• Immune status assessment: pre-treatment and 6 weeks post-radiotherapy.

Main Results:

• Significant immune suppression observed, particularly in patients with bronchogenic carcinomas and head/neck malignancies.
• A trend towards improved PHA reactivity and E-rosette-forming cells post-treatment noted, especially in breast and pelvic tumor patients.
• Immune status normalized with tumor eradication; poor responders showed profound, persistent immune depression.

Conclusions:

• Radiotherapy can induce significant, albeit potentially transient, cell-mediated immune suppression.
• Tumor burden is a key factor influencing immune status during and after radiotherapy.
• Immune status post-treatment may serve as a prognostic indicator for clinical response.